Statistics for AxoGen (id:5348 AXGN)
Valuation metrics
Market cap
653,52M
Enterprise value
700,30M
Trailing P/E (ttm)
-35,39
Forward P/E
47,90
PEG ratio
47,90
Price/Sales (ttm)
3,61
Price/Book (mrq)
6,57
Enterprise Value/Revenue
3,87
Enterprise Value/EBITDA
-378,95
Overview
Shares outstanding
44,01M
Float
38,54M
Shares short
1,09M
% Held by insiders
5,00%
% Held by institutions
3,00%
Average volume (10 days)
184,55K
Average volume (90 days)
Price summary
52-Week low
5,55
52-Week high
18,40
52-Week change
55,96%
Beta
1,13
50-Day moving average
13,88
200-Day moving average
10,28
Dividends and splits
Forward annual dividend rate
4,00
Forward annual dividend yield
3,00
Trailing annual dividend rate
0,00%
Trailing annual dividend yield
0,00
5-Year annual dividend yield
Payout ratio
0,00
Dividend date
February 12, 2010
Ex-dividend date
January 27, 2010
Last split factor
2:1
Last split date
July 11, 1994
Financials
Fiscal yearFiscal year ends
December 31, 2023
Most recent quarter (mrq)
September 30, 2024
Profitability
Profit margin
-7,91%
Operating margin
3,00%
Operational effectiveness
Return on assets
-2,75%
Return on equity
-14,51%
Income statement
Revenue (ttm)
4,16
Revenue per share (ttm)
4,16
Quarterly revenue growth (yoy)
3,00
Gross profit (ttm)
127,87M
EBITDA
-1.848.000,00
Net income to common (ttm)
-14.307.000,00
Diluted EPS (ttm)
3,00
Quarterly earnings growth (yoy)
17,86%
Balance sheet
Total cash (mrq)
24,53M
Total cash per share (mrq)
3,00
Total debt (mrq)
71,31M
Total Debt/Equity (mrq)
71,73
Current ratio (mrq)
374,50%
Book value per share (mrq)
2,26
Cash flow
Cash flow statement
-4.411.000,00
Levered free cash flow (LFCF)
-4.372.250,00